Nitin Joshi

447 posts

Nitin Joshi banner
Nitin Joshi

Nitin Joshi

@DrugSafetyJ

Editor-in-Chief of 𝘿𝙧𝙪𝙜 𝙎𝙖𝙛𝙚𝙩𝙮, the official journal of the International Society of Pharmacovigilance (@ISoPonline). All views are my own.

New Zealand Katılım Mart 2010
116 Takip Edilen1K Takipçiler
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
👉𝙋𝙚𝙣𝙘𝙞𝙡 𝙞𝙣 𝙩𝙝𝙚 𝙙𝙖𝙩𝙚 - 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 7 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 2024 𝗮𝘁 09:00 𝗨𝗧𝗖 @ISoPonline members - Listen to the authors of the 𝗥𝗘𝗔𝗗𝗨𝗦-𝗣𝗩 𝗚𝘂𝗶𝗱𝗲𝗹𝗶𝗻𝗲𝘀 link.springer.com/article/10.100… 👉The presentation will be followed by a Q&A session
Nitin Joshi tweet media
English
0
0
2
127
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
𝘗𝘢𝘳𝘢𝘤𝘦𝘵𝘢𝘮𝘰𝘭 𝘥𝘰𝘴𝘪𝘯𝘨 𝘦𝘳𝘳𝘰𝘳𝘴 𝘤𝘰𝘯𝘵𝘪𝘯𝘶𝘦 𝘵𝘰 𝘰𝘤𝘤𝘶𝘳, 𝘸𝘪𝘵𝘩 𝘳𝘦𝘭𝘢𝘵𝘪𝘷𝘦𝘭𝘺 𝘩𝘪𝘨𝘩 𝘳𝘢𝘵𝘦𝘴 𝘰𝘧 𝘩𝘰𝘴𝘱𝘪𝘵𝘢𝘭𝘪𝘴𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘭𝘪𝘷𝘦𝘳 𝘪𝘯𝘫𝘶𝘳𝘺 link.springer.com/article/10.100… #OpenAccess #Pharmacovigilance #Paracetamol
Nitin Joshi tweet media
English
0
2
0
307
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
𝗖𝗢𝗩𝗜𝗗-19 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗮𝗻𝗱 𝗔𝗰𝘂𝘁𝗲 𝗔𝗽𝗽𝗲𝗻𝗱𝗶𝗰𝗶𝘁𝗶𝘀 Data from Italy showed 𝗡𝗼 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗶𝗼𝗻 between COVID-19 vaccines (BNT162b, ChAdOx1-S, mRNA-1273 and Ad26.COV2-S) and acute appendicitis. link.springer.com/article/10.100… #OpenAccess #Covid19Vaccines
Nitin Joshi tweet media
English
0
0
0
100
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
👉 From 𝗗𝗿𝘂𝗴 𝗦𝗮𝗳𝗲𝘁𝘆 archives 𝗧𝗵𝗲 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗗𝗶𝗰𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝗳𝗼𝗿 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗰𝘁𝗶𝘃𝗶𝘁𝗶𝗲𝘀 (𝗠𝗲𝗱𝗗𝗥𝗔) Full Link rdcu.be/dJ2ED
Nitin Joshi tweet media
English
0
0
5
192
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
Not Just Another Reporting Guideline? Here’s Why READUS-PV is a Major Step Forward Read this commentary for free by our Editorial Board member Professor Yoon Loke University of East Anglia) rdcu.be/dHust #Pharmacovigilance
English
0
1
3
273
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
𝗣𝗲𝗲𝗿 𝗥𝗲𝘃𝗶𝗲𝘄 𝗶𝗻 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗼𝘃𝗶𝗴𝗶𝗹𝗮𝗻𝗰𝗲: 𝗟𝗲𝗻𝘀 𝗼𝗻 𝗗𝗶𝘀𝗽𝗿𝗼𝗽𝗼𝗿𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘁𝘆 𝗔𝗻𝗮𝗹𝘆𝘀𝗶𝘀 It was an excellent experience to work together on this subject alongside some of the leading experts in the field rdcu.be/dBMqB
Nitin Joshi tweet media
English
0
4
9
502
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
👉The Critical Role of Regulations in Pharmacovigilance 👉Guest edited by Kenneth Hartigan-Go and Raymond Chua, this collection highlights the indispensable intersect between health regulations and the discipline of pharmacovigilance. link.springer.com/collections/hd…
Nitin Joshi tweet media
English
0
0
4
199
Nitin Joshi
Nitin Joshi@DrugSafetyJ·
🌟Exciting News! Dr Priya Bahri (EMA) and Pr. Anthony Cox (@Cox_A_R, University of Birmingham) are now part of the Editorial Board of Drug Safety. We extend a warm welcome to both as they become valuable members of the Drug Safety family link.springer.com/journal/40264 #NewBeginnings
English
0
0
5
381